Fig. 3From: Reducing the effective dose of cisplatin using cobalt modified silver nano-hybrid as a carriers on MCF7 and HCT cell modelsX-ray diffraction (XRD) patterns of (a) Cis, (b) CoAg, (c) CoAg@CisBack to article page